We developed a histogram-based CBF analysis method for the prediction of tumor histopathologic grade and molecular marker (including IDH1 mutation, ATRX loss, p53 mutation, MGMT methylation, and 1p/19q co-deletion) in a group of de novo brain glioma patients. ASL MRI may be a non-invasive and cost-effective approach to assist in brain tumor diagnosis and prognosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords